Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kinnari Patel

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Obstetrical & Gynecological Survey|December 30, 2025
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1Claire Booth, Julián Sevilla, Elena Almarza, et al.
The New England Journal of Medicine|April 30, 2025
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1Claire Booth, Julián Sevilla, Elena Almarza, et al.
Blood|July 13, 2018
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology GroupKathryn G Roberts, Shalini C Reshmi, Richard C Harvey, et al.
Lancet (London, England)|January 29, 2017
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trialJohn P Neoptolemos, Daniel H Palmer, Paula Ghaneh, et al.
JAMA Surgery|September 5, 2019
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy TrialRobert P Jones, Eftychia-Eirini Psarelli, Richard Jackson, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Obstetrical & Gynecological Survey|December 30, 2025
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1Claire Booth, Julián Sevilla, Elena Almarza, et al.
The New England Journal of Medicine|April 30, 2025
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1Claire Booth, Julián Sevilla, Elena Almarza, et al.
Blood|July 13, 2018
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology GroupKathryn G Roberts, Shalini C Reshmi, Richard C Harvey, et al.
Lancet (London, England)|January 29, 2017
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trialJohn P Neoptolemos, Daniel H Palmer, Paula Ghaneh, et al.
JAMA Surgery|September 5, 2019
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy TrialRobert P Jones, Eftychia-Eirini Psarelli, Richard Jackson, et al.
Pageof 3